- Home
- AXGN vs CNNE Comparison
AXGN vs CNNE Comparison
Compare AXGN & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- CNNE
- Stock Information
- Founded
- AXGN N/A
- CNNE 2014
- Country
- AXGN United States
- CNNE United States
- Employees
- AXGN N/A
- CNNE N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CNNE Restaurants
- Sector
- AXGN Health Care
- CNNE Consumer Discretionary
- Exchange
- AXGN Nasdaq
- CNNE Nasdaq
- Market Cap
- AXGN 804.8M
- CNNE 869.9M
- IPO Year
- AXGN N/A
- CNNE N/A
- Fundamental
- Price
- AXGN $23.44
- CNNE $17.35
- Analyst Decision
- AXGN Strong Buy
- CNNE Buy
- Analyst Count
- AXGN 7
- CNNE 3
- Target Price
- AXGN $27.71
- CNNE $23.33
- AVG Volume (30 Days)
- AXGN 889.9K
- CNNE 468.5K
- Earning Date
- AXGN 10-29-2025
- CNNE 11-10-2025
- Dividend Yield
- AXGN N/A
- CNNE 3.45%
- EPS Growth
- AXGN N/A
- CNNE N/A
- EPS
- AXGN N/A
- CNNE N/A
- Revenue
- AXGN $214,709,000.00
- CNNE $437,200,000.00
- Revenue This Year
- AXGN $21.57
- CNNE N/A
- Revenue Next Year
- AXGN $15.79
- CNNE N/A
- P/E Ratio
- AXGN N/A
- CNNE N/A
- Revenue Growth
- AXGN 18.72
- CNNE N/A
- 52 Week Low
- AXGN $9.22
- CNNE $15.92
- 52 Week High
- AXGN $24.25
- CNNE $22.36
- Technical
- Relative Strength Index (RSI)
- AXGN 72.25
- CNNE 35.05
- Support Level
- AXGN $23.19
- CNNE $17.52
- Resistance Level
- AXGN $24.25
- CNNE $17.90
- Average True Range (ATR)
- AXGN 1.15
- CNNE 0.41
- MACD
- AXGN 0.47
- CNNE -0.09
- Stochastic Oscillator
- AXGN 86.87
- CNNE 9.70
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.